RxSight Inc. Faces Multiple Securities Class Action Lawsuits
RxSight, Inc., a commercial-stage medical technology company specializing in adjustable intraocular lenses (IOLs), is currently under scrutiny due to multiple class action lawsuits filed by investors. The company, based in Aliso Viejo, United States, operates in the Health Care sector and is listed on the Nasdaq stock exchange. As of July 31, 2025, RxSight’s stock closed at $7.8, with a 52-week high of $58.23 on August 25, 2024, and a low of $6.32 on July 8, 2025. The company’s market capitalization stands at approximately $316.16 million, and it has a negative price-to-earnings ratio of -11.67.
Investor Alert and Lawsuit Details
On August 4, 2025, Berger Montague PC, a nationally recognized securities litigation law firm, announced an investigation into potential securities law violations by RxSight. A class action lawsuit has been filed on behalf of investors who acquired RxSight securities between November 7, 2024, and July 8, 2025. Investors who purchased or acquired RxSight securities during this period have until September 22, 2025, to seek appointment as a lead plaintiff representative of the class.
Similarly, Glancy Prongay & Murray LLP and Robbins Geller Rudman & Dowd LLP have announced opportunities for investors with losses to lead securities fraud class action lawsuits against RxSight. The lawsuits, including Makaveev v. RxSight, Inc., No. 25-cv-01596 (C.D. Cal.), allege that RxSight and certain executives violated the Securities Exchange Act of 1934 by failing to disclose “adoption challenges” and structural issues that led to declines in sales.
Board Appointment
Amidst the legal challenges, RxSight has made a strategic board appointment. On August 4, 2025, the company announced the appointment of Raymond W. Cohen, former founder and CEO of Axonics, to its Board of Directors. This move is seen as an effort to strengthen the company’s leadership and navigate through the ongoing legal and operational challenges.
Conclusion
RxSight Inc. is currently facing significant legal challenges as multiple class action lawsuits have been filed by investors alleging securities law violations. The company’s stock performance has been volatile, with a notable decline from its 52-week high. As the legal proceedings unfold, investors are urged to seek legal advice and consider their options regarding participation in the lawsuits. Meanwhile, the appointment of Raymond W. Cohen to the board may provide strategic guidance to the company during this turbulent period.